chartexchange

Solid Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference

GlobeNewswire Inc. | Nov 10, 2026 8:08 AM EST

CHARLESTOWN, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conference:

Read original article